Depression
- Endocannabinoid system dysfunction in mood and related disorders (PubMed)
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa (PubMed)
- The endocannabinoid system and the treatment of mood and anxiety disorders (PubMed)
- Endocannabinoid signaling in the etiology and treatment of major depressive illness (PubMed)
- Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors(PubMed)
- Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants (PubMed)
- Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa (PubMed)
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress (PubMed)
- Serum contents of endocannabinoids are correlated with blood pressure in depressed women(PubMed)
- The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants (PubMed)
- Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures (PubMed)
- Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa (CNS and Neurological Disorders)
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L (National Institute of Health)
- Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects (Neuropsychiatry Research Unit, Department of Psychiatry, University of Saskatchewan)